September 2026
The SGLT-2 inhibitors market size was USD 19.31 billion in 2026, with leading SGLT-2 inhibitors market players including Boehringer Ingelheim, Eli Lilly and Company.
September 2026
The global cell cycle inhibitors market size was evaluated at USD 6.13 billion in 2026 and is predicted to hit around USD 11.50 billion by 2035, growing at a CAGR of 7.23%.
September 2026
The global bone resorption inhibitors market size was evaluated at USD 4.13 billion in 2026 and is predicted to hit around USD 7.48 billion by 2035, growing at a CAGR of 6.82%.
September 2026
The global calcineurin inhibitors market size was evaluated at USD 11.17 billion in 2026 and is predicted to hit around USD 20.88 billion by 2035, growing at a CAGR of 7.20%.
September 2026
The global clean label mold inhibitors market size reached USD 1.31 billion in 2026 and is projected to be worth around USD 2.24 billion by 2034, with a notable CAGR of 6.93%.
September 2026
The global paraffin inhibitors market size was valued at USD 773.59 million in 2026 and is projected to hit around USD 1,180.61 million by 2035, at a CAGR of 4.81%.
September 2026
The global immune checkpoint inhibitors market size is predicted to hit around USD 258.91 billion by 2035 from USD 68.13 billion in 2025 with a CAGR of 16.03%.
September 2026
The interleukin inhibitors market size was exhibited at USD 34.30 billion in 2026 and is expected to surpass around USD 93.68 billion by 2035 with a CAGR of 11.83%.
September 2026
The global corrosion inhibitors market size was estimated at USD 9.58Â billion in 2026 and is projected to surge around USD 13.34 billion by 2034, with a CAGR of 4.22%.
September 2026
The global lipase inhibitors obesity drugs market size was estimated at USD 1.65 billion in 2026 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
August 2026
The global C5 complement inhibitors market size is estimated to hit around USD 17.83 billion by 2035 increasing from USD 4.85 billion in 2025, with a CAGR of 13.90%.
July 2026
The global VMAT2 inhibitors market size was evaluated at USD 6.04 billion in 2025 and is predicted to hit around USD 15.29 billion by 2035, growing at a CAGR of 9.74%.
April 2026
The global proton pump inhibitors market size is estimated to hit around USD 7.33 billion by 2035 increasing from USD 4.53 billion in 2026, with a CAGR of 5.50%.
January 2025
The global KRAS inhibitors market size is calculated at USD 118.26 million in 2025 and is projected to hit around USD 190.92 million by 2035 with a CAGR of 4.93%
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com